Clinical Pharmacology · Anticholinergic Medications
Muscarinic Antagonists
On this page 5 sections
In 30 seconds
Muscarinic antagonists block acetylcholine at muscarinic receptors, silencing the parasympathetic "rest-and-digest" system. The result is a predictable, opposite-of-cholinergic pattern: dry mouth, blurred vision, fast heart rate, constipation, urinary retention, and hot, flushed skin. The prototype is atropine, but the class includes drugs targeted at the eye, lungs, bladder, gut, and brain, plus many medications that cause anticholinergic effects as an unwanted side property. Because effects are so predictable, this class is a favorite for testing organ-system reasoning and toxidrome recognition.
The college version
Mechanism and the organ-by-organ pattern
Muscarinic receptors are G-protein-coupled receptors activated by acetylcholine at parasympathetic nerve endings supplying the eye, glands, heart, lungs, GI tract, and bladder. Muscarinic antagonists (antimuscarinics) are competitive blockers at these receptors: they occupy the receptor without activating it, preventing acetylcholine from producing its normal effect. Because parasympathetic tone normally slows the heart, constricts pupils, stimulates secretions, and promotes gut and bladder emptying, blocking it does the reverse everywhere at once. This produces the classic toxidrome mnemonic: "hot as a hare" (hyperthermia from lost sweating), "dry as a bone" (no salivary, sweat, or mucus secretions), "red as a beet" (cutaneous flushing as the body tries to dump heat), "blind as a bat" (mydriasis and cycloplegia impair near vision), and "mad as a hatter" (CNS muscarinic blockade causing confusion, agitation, or delirium). Tachycardia and urinary retention round out the picture.
Prototype and related nonselective agents
Atropine is the reference antimuscarinic, used for bradycardia and as an antidote in cholinergic (organophosphate) poisoning. Scopolamine crosses the blood-brain barrier readily and is used for motion sickness, exploiting its strong CNS and vestibular antimuscarinic action, though this same property causes sedation and confusion. Glycopyrrolate is a quaternary amine antimuscarinic used to dry secretions before surgery and to blunt bradycardia; because quaternary ammonium compounds carry a permanent positive charge, they cross lipid membranes poorly and largely stay out of the CNS, giving fewer central effects than atropine or scopolamine.
Respiratory-targeted agents
Ipratropium and tiotropium are inhaled quaternary antimuscarinics used in asthma and COPD. Blocking muscarinic receptors in bronchial smooth muscle produces bronchodilation. Their inhaled route and quaternary structure keep systemic and CNS absorption low, concentrating the effect in the lungs.
Bladder-targeted agents
Oxybutynin, tolterodine, and solifenacin are antimuscarinics used for overactive bladder. Detrusor muscle contraction is muscarinic-receptor-driven, so blocking it reduces urgency and involuntary contractions. Oxybutynin is more lipophilic and tends to produce more classic dry-mouth and CNS side effects than newer, more receptor-selective agents like solifenacin.
GI-targeted agents
Dicyclomine and hyoscyamine are antimuscarinics used for GI smooth-muscle spasm, as in irritable bowel syndrome, by relaxing hypermotile gut muscle.
CNS-targeted agents for extrapyramidal symptoms
Benztropine and trihexyphenidyl are centrally active antimuscarinics used to treat drug-induced extrapyramidal symptoms from antipsychotics. In the basal ganglia, dopamine normally inhibits and acetylcholine normally excites motor circuits; antipsychotic dopamine blockade tips this balance toward excess cholinergic activity, producing rigidity and tremor. Antimuscarinics restore balance by damping the cholinergic side.
Incidental anticholinergic burden
Many drugs not prescribed for antimuscarinic effect still block muscarinic receptors as an off-target property: first-generation antihistamines (e.g., diphenhydramine), tricyclic antidepressants, and some antipsychotics. Taken together or in older adults, these add up to significant "anticholinergic burden," a cumulative load tracked because it correlates with falls, constipation, and cognitive impairment.
Contraindications, cautions, and antidote
Antimuscarinics are used cautiously or avoided in narrow-angle glaucoma (pupil dilation can precipitate an acute pressure crisis), benign prostatic hyperplasia and urinary retention (further relaxation of bladder outflow worsens retention), and GI obstruction (further slowing of motility is dangerous). Heat intolerance is a concern in hot environments or with exertion because sweating is blocked. Older adults are especially vulnerable to delirium and falls, which is why anticholinergic burden is explicitly flagged in the Beers Criteria for potentially inappropriate medications in this population. In severe antimuscarinic toxicity with dangerous agitation, delirium, or arrhythmia, physostigmine, a cholinesterase inhibitor that crosses into the CNS, can reverse both central and peripheral antimuscarinic effects by allowing acetylcholine to accumulate and outcompete the blockade.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine your body has a "calm down and digest" switch that acetylcholine flips on: it makes spit, slows your heart, shrinks your pupils, and gets your stomach and bladder working. Muscarinic antagonist drugs are like sticking gum in that switch so it can't be flipped. Nothing turns on, so everything goes the opposite way: your mouth goes dry, your heart speeds up, your pupils get huge so you can't see up close, you stop sweating so you get hot, and your skin turns red trying to cool off. Some of these gum-in-the-switch drugs only reach switches in one place, like just the lungs (for breathing problems) or just the bladder (so you don't need to pee constantly), because they're built with a "no entry" tag that keeps them out of the brain. Others, like atropine or scopolamine, can sneak into the brain too, which is why they can make someone confused or sleepy, not just dry and flushed. Doctors have to be extra careful giving these to older people, because being confused and unsteady is more dangerous for them.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
An elderly patient taking diphenhydramine nightly for sleep, along with a tricyclic antidepressant, develops new confusion and constipation over several weeks. What pharmacologic concept explains this, and why are older adults especially at risk?
Show answer
(open answer)
This is anticholinergic burden: each drug alone blocks muscarinic receptors only mildly, but taken together their antimuscarinic effects add up to a much bigger total blockade. Older adults are more vulnerable because they often have less brain reserve and slower drug clearance, so the same cumulative dose produces more confusion, delirium, and constipation than it would in a younger person — this is why such combinations are flagged in the Beers Criteria.
A patient who took a large dose of an antimuscarinic agent presents with severe agitation, delirium, hyperthermia, and tachycardia. Which drug could be used to reverse this, and what is its mechanism?
Show answer
(open answer)
Physostigmine can reverse this. It is a cholinesterase inhibitor that crosses into the brain, so it stops the enzyme that normally breaks down acetylcholine, letting acetylcholine build up and out-compete the antimuscarinic drug at receptors throughout the body and brain, reversing both the central agitation/delirium and the peripheral hyperthermia and tachycardia.
Quick check
3 questions here. Answers stay hidden until you check.
Why do glycopyrrolate and ipratropium produce fewer central nervous system effects than atropine or scopolamine?
A patient with untreated narrow-angle glaucoma is prescribed a new medication for overactive bladder. What is the main concern?
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

